SEAN STEHR: Open Payments
NPI 1245433234 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 30 payments from 8 companies in 2025. Trend: 2023 $404 · 2024 $767 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $231 |
| Stryker Corporation | 1 | $144 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| Valinor Pharma, LLC | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| PFIZER INC. | 3 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, AJOVY, MOVANTIK, UBRELVY, RELISTOR, NURTEC ODT, JOURNAVX, Belbuca.
Industry payments across LA — which companies pay providers there.
